A detailed history of Measured Wealth Private Client Group, LLC transactions in Organon & Co. stock. As of the latest transaction made, Measured Wealth Private Client Group, LLC holds 35,586 shares of OGN stock, worth $520,267. This represents 0.17% of its overall portfolio holdings.

Number of Shares
35,586
Previous 21,137 68.36%
Holding current value
$520,267
Previous $404,000 31.19%
% of portfolio
0.17%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025

BUY
$14.44 - $18.83 $208,643 - $272,074
14,449 Added 68.36%
35,586 $530,000
Q3 2024

Oct 25, 2024

BUY
$18.65 - $23.03 $105,241 - $129,958
5,643 Added 36.42%
21,137 $404,000
Q2 2024

Aug 12, 2024

BUY
$17.45 - $21.96 $270,370 - $340,248
15,494 New
15,494 $320,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.72B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Measured Wealth Private Client Group, LLC Portfolio

Follow Measured Wealth Private Client Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Measured Wealth Private Client Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Measured Wealth Private Client Group, LLC with notifications on news.